See more : Liaoning Oxiranchem,Inc. (300082.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Brilliant Acquisition Corporation (BRLI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Brilliant Acquisition Corporation, a leading company in the Shell Companies industry within the Financial Services sector.
- Uniti Group Inc. (0LJB.L) Income Statement Analysis – Financial Results
- AudioCodes Ltd. (AUDC) Income Statement Analysis – Financial Results
- TG Venture Acquisition Corp. (TGVC) Income Statement Analysis – Financial Results
- Dogan Sirketler Grubu Holding A.S. (DOHOL.IS) Income Statement Analysis – Financial Results
- Trajan Group Holdings Limited (TRJ.AX) Income Statement Analysis – Financial Results
Brilliant Acquisition Corporation (BRLI)
Industry: Shell Companies
Sector: Financial Services
About Brilliant Acquisition Corporation
Brilliant Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2019 and is based in Shanghai, China.
Metric | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 1.20M | 670.92K | 148.01K | 0.00 |
Gross Profit | -1.20M | -670.92K | -148.01K | 0.00 |
Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 1.20K | 670.92 | 148.01 | 35.42 |
Other Expenses | 1.20M | 670.92K | 148.01K | 0.00 |
Operating Expenses | 1.20M | 670.92K | 148.01K | 35.42 |
Cost & Expenses | 1.20M | 670.92K | 148.01K | 35.42 |
Interest Income | 64.95K | 4.63K | 3.06K | 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | -169.84K | -67.16K | 172.79K | 171.86K |
EBITDA | -1.37M | -670.92K | 24.78K | 0.00 |
EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -1.20M | -670.92K | -148.01K | -35.42 |
Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 234.79K | 71.79K | -169.73K | 0.00 |
Income Before Tax | -967.61K | -599.13K | -317.74K | -35.42 |
Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | -234.79K | -4.63K | -3.06K | 0.00 |
Net Income | -732.83K | -594.49K | -314.68K | -35.42 |
Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -0.16 | -0.10 | -0.09 | 0.00 |
EPS Diluted | -0.16 | -0.10 | -0.09 | 0.00 |
Weighted Avg Shares Out | 4.64M | 6.11M | 3.70M | 0.00 |
Weighted Avg Shares Out (Dil) | 4.64M | 6.11M | 3.70M | 0.00 |
Analysts Expect Opko Health Inc. (NASDAQ:OPK) Will Post Earnings of -$0.09 Per Share
Opko Health Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Purchases 100,000 Shares
Opko Health (NASDAQ:OPK) Sees Unusually-High Trading Volume
OPKO Health News: Why OPK Health Stock Is Soaring 30% Today
Benzinga Pro's Top 5 Stocks To Watch For Fri., Mar. 13, 2020: GLD, OPK, IBIO, CPB, CANF
Insider Buying: Opko Health Inc. (NASDAQ:OPK) CEO Acquires 300,000 Shares of Stock
Mackay Shields LLC Acquires 21,800 Shares of Opko Health Inc. (NASDAQ:OPK)
Edited Transcript of OPK earnings conference call or presentation 26-Feb-20 9:30pm GMT
Piper Sandler Reaffirms "Buy" Rating for Opko Health (NASDAQ:OPK)
Source: https://incomestatements.info
Category: Stock Reports